Canon and Olympus team up to take on ultrasonography market
The deal between the two firms means that they will collaborate on the production of Canon’s Aplio i8002 diagnostic ultrasound system.
15 January 2024
15 January 2024
The deal between the two firms means that they will collaborate on the production of Canon’s Aplio i8002 diagnostic ultrasound system.
Artificial intelligence-based software BrainSee received breakthrough designation from the US Food and Drug Administration in 2021.
Depending on clinical results, the US startup could enter a crowded but fertile thrombectomy market which is predicted to grow to $2.5bn by 2033.
Prenatal screenings typically involve testing for potentially harmful STIs.
Experts are utilising cutting-edge 3D-printing technology to successfully produce complex functional human organs.
The upcoming two-day event delves into what medical device developers need to know about EU MDR and utilising AI in medical device trials.
Nexalin is engaging with the FDA to plan clinical trials to investigate the HALO Clarity device as an at-home treatment for a variety of mental health conditions.
The approval of VISUMAX 800 comes after the announcement of ZEISS’ $1bn deal with Dutch Ophthalmic Research Center.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Cybersecurity is a growing market in the medical devices sector for several reasons. Medical devices often collect and contain vulnerable data, such as patient medical information. Legacy medical devices are a cause for concern because they likely were not designed with cyberattacks in mind. With the adoption of EHR systems, telemedicine measures, mobile health apps, and other connected devices, there is increased vulnerability to cyberattacks.
Give your business an edge with our leading industry insights.